AbbVie ( ABBV 0.64%) is a leader in biopharmaceuticals with a product portfolio spanning multiple therapeutic areas, ...
SELLAS Life Sciences CEO Angelos Stergiou and "Some Future Day" author Marc Beckman predict artificial intelligence will ...
11h
News Medical on MSNAI-based technology accelerates discovery of new tuberculosis drug candidatesTuberculosis is a serious global health threat that infected more than 10 million people in 2022. Spread through the air and into the lungs, the pathogen that causes "TB" can lead to chronic cough, ...
Andrew Pierce, senior executive at French biotech Owkin, on how artificial intelligence can make the drug development process ...
Researchers have used artificial intelligence to identify 25 new protein compounds that can kill bacteria and fungi, ...
4d
24/7 Wall St. on MSNCathie Wood's Top Biotech Plays for FebruaryDon’t look now, but Cathie Wood of Ark Invest is fresh off an impressive comeback year, with her broader basket of disruptive ...
Debut, the biotech beauty leader, announced today the launch of BeautyORBâ„¢, an AI-powered innovation engine that provides a ...
AI-powered simulation software could help biomanufacturers understand the economics and sustainability of protein production at large scale.
Biotechnology company The Cultivated B has introduced a new AI-driven biosensor system designed to enhance real-time ...
As one of the largest tuberculosis outbreaks in the U.S. unfolds in Kansas, UC San Diego researchers and their colleagues ...
Tempus AI's innovative products are transforming the healthcare industry, with a focus on oncology and large market ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results